HPVDNAtesting
HPVDNAtesting refers to a molecular diagnostic technique used to detect the presence of human papillomavirus (HPV) DNA in clinical specimens, most commonly cervical swabs. The test employs polymerase chain reaction (PCR) amplification of specific HPV genomic regions followed by sequencing or hybridization to identify high‑risk oncogenic types. By targeting DNA rather than protein expressed through viral antigens, the assay is able to detect asymptomatic infections and infections that may not produce pronounced cellular changes.
The primary clinical application of HPVDNAtesting is in cervical cancer screening. In many screening programs it
Sensitivity and specificity of HPVDNAtesting vary with the assay platform. Many assays detect the 14 high‑risk
Limitations of HPVDNAtesting include false‑positive results from transient infections, particularly in younger women, and the cost